Navigation Links
Leading Denture Cream Litigation Firm Welcomes GSK Announcement of Removal of Zinc From Its Denture Creams

Untold Numbers of Consumers Still Left Disabled By Its Products

WASHINGTON, Feb. 18 /PRNewswire-USNewswire/ -- GlaxoSmithKline, the maker of popular denture adhesives Poligrip and Super Poligrip, announced today that it will remove zinc from all of its denture adhesive products.  The pharmaceutical giant has added the potentially hazardous mineral to its adhesives for decades, despite overwhelming evidence that consuming large quantities of zinc over an extended period of time can cause serious neurological damage.

The leading national pharmaceutical litigation firm, Blizzard, McCarthy and Nabers, which represents dozens of consumers poisoned by denture cream zinc, welcomed the announcement:

"Representing dozens of patients poisoned by zinc in denture cream, we have seen the damage wrought by this toxin," said attorney Ed Blizzard.  "Today's announcement is a responsible action for GSK to take and a victory for consumers.  Unfortunately, it comes far too late for the hundreds - if not thousands - of people who have been crippled by zinc poisoning.  While we applaud the efforts of GlaxoSmithKline to make their products safer, the reality is, it should have removed zinc from its adhesives years ago."

Currently, about 70 lawsuits have been filed in Miami's Multi-District Litigation against both GlaxoSmithKline and Proctor & Gamble, makers of denture adhesive containing zinc. And at least 20 other mass tort claims have been filed in Philadelphia, where GlaxoSmithKline's headquarters are located.  Recently, Blizzard was named to the Plaintiffs' Steering Committee for the Miami MDL.

"While today's announcement is a positive step, consumers are still largely unaware of the dangers posed by zinc-laced denture adhesives," said Scott Nabers, partner at Blizzard, McCarthy and Nabers, who is handling the firm's cases in the Philadelphia Mass Tort Program.  "Poligrip products are also not the only adhesives on the market spiked with the mineral. Procter & Gamble, the makers of Fixodent, should also withdraw it's zinc-containing denture cream product as it carries the same zinc poisoning risks to consumers."

Over the last two years, three separate scientific studies have reported a direct connection between the use of zinc-laden denture adhesives and serious neurological disorders such as neuropathy.  A 2008 study published in Neurology concluded, "chronic excessive use [of denture adhesives] may result in…serious neurological disease."  Another study published last year in NeuroToxicology identified 11 patients suffering zinc-related neurological damage and concluded that the "use of denture cream appear[ed] to be the sole source of excess zinc in these patients."

GSK's statement on its decision to remove zinc from its products can be found here:

For more information, see stories in the Fort Worth Star-Telegram and the St. Petersburg Times.

More information about denture cream is available at

Blizzard, McCarthy & Nabers, LLC, one of the nation's leading pharmaceutical litigation firms, represents thousands of clients harmed by dangerous drugs and medical devices and has taken on some of the world's largest corporations, including Bristol-Myers, GlaxoSmithKline, Merck, Pfizer and Dow Chemical.

SOURCE Blizzard, McCarthy & Nabers, LLC

SOURCE Blizzard, McCarthy & Nabers, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. World-Leading Alcohol Abuse Lab Status for Trimega
2. Leading Japanese University Powers Diagnostic Imaging Research With Isilon IQ
3. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
4. Reportlinker Adds Top Ten Worlds Leading Orthopedics Companies
5. First CyberKnife in Belgium to be Installed at Leading University Hospital
6. Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker
7. MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA
8. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health, First-Ever Leading Calcium Supplement to Help Support Bone AND Heart Health
9. Leading Event for People With Disabilities on November 6-8 Features Latest Technologies, Products, Services, and More
10. St. Davids South Austin Hospital Leading the Central Texas Region in Laser-Assisted Lead-Extraction Procedures
11. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
Post Your Comments:
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
Breaking Medicine Technology:
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):